Lipid Panel Test (LPT), or total lipid profile or lipid panel is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, such as cholesterol and triglycerides. This test enables diagnosis of lipid disorders along with risk for coronary heart disease. There is a high correlation between coronary heart diseases (CHD) with abnormal lipid levels. These tests provides value for serum lipids such as total cholesterol, TG, HDL cholesterol, and VLDL. LPT market includes diagnostic services along with equipment and consumables such as analyzers, integrated systems, and lipid profile cassettes. The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases.
This report contains market size and forecasts of Lipid Panel Test in Global, including the following market information:
Global Lipid Panel Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lipid Panel Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hyperlipidemia Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lipid Panel Test include Abbott Laboratories, Avanti Polar Lipids, Inc., Beckman Coulter, Inc., EuroMedixPOC, F. Hoffmann-La Roche Ltd, Alere Inc., PTS Diagnostics, Quest Diagnostics and Randox Laboratories Ltd and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lipid Panel Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lipid Panel Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lipid Panel Test Market Segment Percentages, by Type, 2021 (%)
Hyperlipidemia
Hypertriglyceridemia
Familial Hypercholesterolemia
Hyperlipoproteinemia
Tangier Disease
Others
Global Lipid Panel Test Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lipid Panel Test Market Segment Percentages, by Application, 2021 (%)
Home
Diagnostic Laboratories
Hospital
Global Lipid Panel Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lipid Panel Test Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lipid Panel Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lipid Panel Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Avanti Polar Lipids, Inc.
Beckman Coulter, Inc.
EuroMedixPOC
F. Hoffmann-La Roche Ltd
Alere Inc.
PTS Diagnostics
Quest Diagnostics
Randox Laboratories Ltd
Thermo Fisher Scientific Inc